Literature DB >> 6327770

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

T A Waldmann, W C Greene, P S Sarin, C Saxinger, D W Blayney, W A Blattner, C K Goldman, K Bongiovanni, S Sharrow, J M Depper.   

Abstract

Adult T cell leukemia (ATL) and Sézary leukemia are malignant proliferations of T lymphocytes that share similar cell morphology and clinical features. ATL is associated with HTLV (human T cell leukemia/lymphoma virus), a unique human type C retrovirus, whereas most patients with the Sézary syndrome do not have antibodies to this virus. Leukemic cells of both groups were of the T3, T4-positive, T8-negative phenotype. Despite the similar phenotype, HTLV-negative Sézary leukemic cells frequently functioned as helper cells, whereas some HTLV-positive ATL and HTLV-positive Sézary cells appeared to function as suppressors of immunoglobulin synthesis. One can distinguish the HTLV-positive from the HTLV-negative leukemias using a monoclonal antibody (anti-Tac) that appears to identify the human receptor for T cell growth factor (TCGF). Resting normal T cells and most HTLV-negative Sézary cells were Tac-negative, whereas all ATL cell populations were Tac-positive. The observation that ATL cells manifest TCGF receptors suggests the possibility that an abnormality of the TCGF-TCGF receptor system may partially explain the uncontrolled growth of these cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327770      PMCID: PMC437083          DOI: 10.1172/JCI111379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody.

Authors:  M Robert-Guroff; K A Fahey; M Maeda; Y Nakao; Y Ito; R C Gallo
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

3.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

4.  Characterization of the human receptor for T-cell growth factor.

Authors:  W J Leonard; J M Depper; R J Robb; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

5.  Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma.

Authors:  R C Gallo; D Mann; S Broder; F W Ruscetti; M Maeda; V S Kalyanaraman; M Robert-Guroff; M S Reitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

7.  Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor.

Authors:  Z Lando; P Sarin; M Megson; W C Greene; T A Waldman; R C Gallo; S Broder
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

8.  The human T-cell leukemia-lymphoma virus in the southeastern United States.

Authors:  D W Blayney; W A Blattner; M Robert-Guroff; E S Jaffe; R I Fisher; P A Bunn; M G Patton; H R Rarick; R C Gallo
Journal:  JAMA       Date:  1983-08-26       Impact factor: 56.272

9.  Epidemiology of human T-cell leukemia/lymphoma virus.

Authors:  W A Blattner; D W Blayney; M Robert-Guroff; M G Sarngadharan; V S Kalyanaraman; P S Sarin; E S Jaffe; R C Gallo
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

10.  Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.

Authors:  W E Biddison; P E Rao; M A Talle; G Goldstein; S Shaw
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  31 in total

1.  Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38.

Authors:  Ronit Mazor; Gilad Kaplan; Dong Park; Youjin Jang; Fred Lee; Robert Kreitman; Ira Pastan
Journal:  Cell Immunol       Date:  2017-01-05       Impact factor: 4.868

Review 2.  Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia.

Authors:  M R Smith; W C Greene
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

3.  Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Authors:  Jonathan L Berkowitz; John E Janik; Donn M Stewart; Elaine S Jaffe; Maryalice Stetler-Stevenson; Joanna H Shih; Thomas A Fleisher; Maria Turner; Nicole E Urquhart; Gilian H Wharfe; William D Figg; Cody J Peer; Carolyn K Goldman; Thomas A Waldmann; John C Morris
Journal:  Clin Immunol       Date:  2014-09-28       Impact factor: 3.969

4.  Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth.

Authors:  Y Wano; M Feinberg; J B Hosking; H Bogerd; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells.

Authors:  F Miedema; J W van Oostveen; F G Terpstra; A W van den Wall Bake; R Willemze; E A Rauws; R Bieger; M B van 't Veer; D Catovsky; C J Melief
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

6.  90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Authors:  John E Janik; John C Morris; Deirdre O'Mahony; Stefania Pittaluga; Elaine S Jaffe; Christophe E Redon; William M Bonner; Martin W Brechbiel; Chang H Paik; Millie Whatley; Clara Chen; Jae-Ho Lee; Thomas A Fleisher; Maggie Brown; Jeffrey D White; Donn M Stewart; Suzanne Fioravanti; Cathryn C Lee; Carolyn K Goldman; Bonita R Bryant; Richard P Junghans; Jorge A Carrasquillo; Tat'Yana Worthy; Erin Corcoran; Kevin C Conlon; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

7.  90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.

Authors:  Kevin C Conlon; Claude Sportes; Martin W Brechbiel; Daniel H Fowler; Ronald Gress; Milos D Miljkovic; Clara C Chen; Millie A Whatley; Bonita R Bryant; Erin M Corcoran; Karen A Kurdziel; Stefania Pittaluga; Chang H Paik; Jae Ho Lee; Thomas A Fleisher; Jorge A Carrasquillo; Thomas A Waldmann
Journal:  Cancer Biother Radiopharm       Date:  2020-04-09       Impact factor: 3.099

8.  Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

Authors:  Elisabetta Capriotti; Eric C Vonderheid; Christopher J Thoburn; Mariusz A Wasik; David W Bahler; Allan D Hess
Journal:  Leuk Lymphoma       Date:  2008-06

9.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  J D Burton; R N Bamford; C Peters; A J Grant; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides.

Authors:  D Zucker-Franklin; E E Coutavas; M G Rush; D C Zouzias
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.